D. Boral Capital Downgrades FibroBiologics to Hold

Benzinga Newsdesk www.benzinga.com Negative 91.8%

Neg 91.8% Neu 0% Pos 0%

D. Boral Capital analyst Jason Kolbert downgrades FibroBiologics (NASDAQ:FBLG) from Buy to Hold.

Comments

No comments yet. Be the first!